ALLO-647
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ALLO-647, covering 2025-12-31 to 2025-12-31. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell Therapy [Phase 2]